drugset
drugset / Trial / NCT04877678

Effects of Second-generation Antihistamine Bepotastine on Cough Outcomes in Cough Patients With Allergic Rhinitis

NCT04877678 ↗

Phase 4 Completed 50 enrolled Asan Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a phase 4 study to evaluate the the efficacy of second generation antihistamine on cough outcomes in cough patients with allergic rhinitis.

Timeline

Start
2021-10-01
Primary completion
2022-09-01
Completion
2022-10-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bepotastine Small molecule 10 mg Oral

Indications

allergic rhinitis